Khaled Ali

2.1k total citations
26 papers, 1.6k citations indexed

About

Khaled Ali is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Khaled Ali has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Khaled Ali's work include COVID-19 Pandemic Impacts (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and COVID-19 and Mental Health (3 papers). Khaled Ali is often cited by papers focused on COVID-19 Pandemic Impacts (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and COVID-19 and Mental Health (3 papers). Khaled Ali collaborates with scholars based in Qatar, United Kingdom and Egypt. Khaled Ali's co-authors include Bart Vanhaesebroeck, Antonio Bilancio, Klaus Okkenhaug, Lazaros C. Foukas, Barbara Geering, Wayne Pearce, Cheryl L. Scudamore, Ee Lyn Lim, Hicham Bouabe and Roberto Piñeiro and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Khaled Ali

21 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled Ali Qatar 10 787 728 420 350 186 26 1.6k
Leonardo Vargas Sweden 18 746 0.9× 687 0.9× 197 0.5× 518 1.5× 117 0.6× 30 1.6k
Paul J. Coffer Netherlands 18 1.4k 1.7× 452 0.6× 353 0.8× 145 0.4× 177 1.0× 27 2.1k
Céline Charvet France 18 1.0k 1.3× 608 0.8× 443 1.1× 85 0.2× 78 0.4× 26 1.7k
Sylvia Kaden Germany 16 755 1.0× 379 0.5× 319 0.8× 160 0.5× 150 0.8× 23 1.6k
Jasper de Boer United Kingdom 22 1.2k 1.5× 787 1.1× 342 0.8× 143 0.4× 99 0.5× 43 2.2k
Wendy S. Halsey United States 13 536 0.7× 274 0.4× 371 0.9× 117 0.3× 208 1.1× 19 1.3k
Frank C. Stomski Australia 23 727 0.9× 800 1.1× 463 1.1× 131 0.4× 130 0.7× 35 1.8k
Kenneth S. Zuckerman United States 24 598 0.8× 343 0.5× 318 0.8× 330 0.9× 114 0.6× 67 1.5k
Andreas Hadjisavvas Cyprus 22 652 0.8× 341 0.5× 215 0.5× 83 0.2× 94 0.5× 76 1.6k
Dorota Wyczechowska United States 18 881 1.1× 1.1k 1.5× 594 1.4× 128 0.4× 91 0.5× 50 2.2k

Countries citing papers authored by Khaled Ali

Since Specialization
Citations

This map shows the geographic impact of Khaled Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Ali more than expected).

Fields of papers citing papers by Khaled Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Ali. The network helps show where Khaled Ali may publish in the future.

Co-authorship network of co-authors of Khaled Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Ali. A scholar is included among the top collaborators of Khaled Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Ali. Khaled Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ali, Khaled, et al.. (2024). Diffuse large B‐cell lymphoma presenting with pulmonary artery compression symptoms, case reports. SHILAP Revista de lepidopterología. 12(8). e01441–e01441. 1 indexed citations
3.
Ali, Khaled, et al.. (2024). Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar. Qatar medical journal. 2023(4). 33–33. 1 indexed citations
4.
Baranwal, Anmol, Khaled Ali, Mohamed A. Kharfan‐Dabaja, et al.. (2023). Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis. Transplantation and Cellular Therapy. 29(2). S9–S10. 1 indexed citations
5.
Ali, Khaled, et al.. (2023). Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome. Heliyon. 9(8). e18716–e18716. 1 indexed citations
7.
Al-Jayyousi, Ghadir Fakhri, Mohammed Nour, Khaled Ali, et al.. (2022). Barriers to Practicing COVID-19 Preventive Behaviors Among Migrant Workers in Qatar: A Qualitative Study During the First Wave of the Pandemic. International Journal of Public Health. 67. 1604881–1604881. 2 indexed citations
8.
Ali, Khaled, et al.. (2022). Experimental study on synovial fluid matrix metalloproteinases in dogs affected with osteoarthritis. Veterinary Medical Journal Giza. 0(0). 49–63.
9.
Ali, Khaled, et al.. (2022). COVID-19 perceived stigma among survivors: A cross-sectional study of prevalence and predictors. The European Journal of Psychiatry. 37(1). 24–35. 7 indexed citations
10.
Ali, Khaled, et al.. (2021). Bronchopleural fistula causing persistent pneumothorax in COVID‐19 pneumonia patient with no risk factors. SHILAP Revista de lepidopterología. 9(11). e05128–e05128. 3 indexed citations
11.
Elshafei, Mohamed Nabil, et al.. (2021). Eslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure. SHILAP Revista de lepidopterología. 9(11). e04851–e04851. 3 indexed citations
13.
Ali, Khaled, et al.. (2021). Potential Toxicity Evaluation for a Nano-modified Veneering Ceramic System. Experimental Study in Dogs. Egyptian Dental Journal . 67(1). 531–536. 1 indexed citations
14.
Sckisel, Gail D., Anupama Sahoo, Almin Lalani, et al.. (2020). Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. Frontiers in Immunology. 11. 832–832. 55 indexed citations
15.
Alliouachene, Samira, Benoît Bilanges, Gaëtan Chicanne, et al.. (2015). Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity. Cell Reports. 13(9). 1881–1894. 62 indexed citations
16.
Ali, Khaled, Dalya R. Soond, Roberto Piñeiro, et al.. (2014). Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 510(7505). 407–411. 397 indexed citations
17.
Ali, Khaled, Montserrat Camps, Wayne Pearce, et al.. (2008). Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110δ but Not p110γ Promotes Optimal Allergic Responses In Vivo. The Journal of Immunology. 180(4). 2538–2544. 99 indexed citations
18.
Okkenhaug, Klaus, Khaled Ali, & Bart Vanhaesebroeck. (2007). Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K. Trends in Immunology. 28(2). 80–87. 100 indexed citations
19.
Vanhaesebroeck, Bart, Khaled Ali, Antonio Bilancio, Barbara Geering, & Lazaros C. Foukas. (2005). Signalling by PI3K isoforms: insights from gene-targeted mice. Trends in Biochemical Sciences. 30(4). 194–204. 356 indexed citations
20.
Ali, Khaled, Antonio Bilancio, Matthew J. Thomas, et al.. (2004). Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature. 431(7011). 1007–1011. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026